News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Labopharm Inc. Posts Wider Loss, Revenue Rises
November 11, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
TORONTO, Nov 11 (Reuters) - Canada's Labopharm Inc (DDS.TO), which specializes in controlled-release drugs, posted on Thursday a wider net loss as higher sales and marketing expenses offset improved revenue.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Layoff Tracker
Pfizer, Geron Downsize To Streamline Costs
December 12, 2025
·
95 min read
·
BioSpace Editorial Staff
Weight loss
Zealand Bets up to $2.5B in Metabolic Pact With Chinese Biotech
December 11, 2025
·
2 min read
·
Tristan Manalac
Layoffs
Pfizer’s Cost Cuts Claim 200+ Jobs in Switzerland: Report
December 11, 2025
·
2 min read
·
Tristan Manalac
Regulatory
Regeneron Climbs Back After a Year of Regulatory, Manufacturing Misery
December 10, 2025
·
3 min read
·
Annalee Armstrong
